News
-
Everything You Need Know About Pregabalin And Methylcobalamin Capsules
What are pregabalin and methylcobalamin capsules? Pregabalin and methylcobalamin capsules are a combination of two medicines: pregabalin and methylcobalamin. Pregabalin acts by decreasing the number of pain signals sent by a damaged nerve in the body, and meth...Read more -
ALL ABOUT HYDROCHLOROTHIAZIDE
Hydrochlorothiazide manufacturers explain everything essential about hydrochlorothiazide to help you know better about it. What is hydrochlorothiazide? Hydrochlorothiazide (HCTZ) is a thiazide diuretic that helps prevent your body from absorbing too much salt, which can ...Read more -
Bayer’s new heart drug Vericiguat is approved in China
On May 19, 2022, China’s National Medical Products Administration (NMPA) approved the marketing application for Bayer’s Vericiguat (2.5 mg, 5 mg, and 10 mg) under the brand name Verquvo™. This drug is used in adult patients with symptomatic chronic heart failure and red...Read more -
Three major differences between Ruxolitinib and Ruxolitinib cream
Ruxolitinib is a type of oral targeted therapy called a kinase inhibitor and is mainly used to treat diseases such as graft-versus-host disease, erythroblastosis, and medium-and high-risk myelofibrosis, while Ruxolitinib cream is a topical dermatological agent that is ap...Read more -
Considerations when taking Ruxolitinib for the first time
Ruxolitinib is a type of targeted cancer drug. It is mainly used to inhibit the activation of the JAK-STAT signaling pathway and lower the signal that suppresses the abnormal enhancement, thus achieving therapeutic effect. It works by...Read more -
Ruxolitinib significantly reduces disease and improves quality of life in patients
The treatment strategy for primary myelofibrosis (PMF) is based on risk stratification. Due to the variety of clinical manifestations and issues to be addressed in PMF patients, treatment strategies need to take into acco...Read more -
Ruxolitinib has promising efficacy in myeloproliferative diseases
Ruxolitinib, also known as ruxolitinib in China, is one of the "new drugs" that have been widely listed in clinical guidelines for the treatment of hematological diseases in recent years, and has shown promising efficacy in myeloproliferative diseases. The targeted drug ...Read more -
Heart disease needs a new drug – Vericiguat
Heart failure with reduced ejection fraction (HFrEF) is a major type of heart failure, and the China HF Study showed that 42% of heart failures in China are HFrEF, although several standard therapeutic classes of drugs are available for HFrEF and have reduced the risk of...Read more -
Targeted drug for the treatment of myelofibrosis: Ruxolitinib
Myelofibrosis (MF) is referred to as myelofibrosis. It is also a very rare disease. And the cause of its pathogenesis is not known. Typical clinical manifestations are juvenile red blood cell and juvenile granulocytic anemia with a high number of tear drop red blood cell...Read more -
You should know at least these 3 points about rivaroxaban
As a new oral anticoagulant, rivaroxaban has been widely used in the prevention and treatment of venous thromboembolic disease and stroke prevention in non-valvular atrial fibrillation. In order to use rivaroxaban more reasonably, you should know at least these 3 points....Read more -
Changzhou Pharmaceutical received approval to produce Lenalidomide Capsules
Changzhou Pharmaceutical Factory Ltd., a subsidiary of Shanghai Pharmaceutical Holdings, received the Drug Registration Certificate (Certificate No. 2021S01077, 2021S01078, 2021S01079) issued by the State Drug Administration for Lenalidomide Capsules (Specification 5mg, ...Read more -
What are the precautions for rivaroxaban tablets?
Rivaroxaban, as a new oral anticoagulant, has been widely used in the prevention and treatment of venous thromboembolic diseases. What do I need to pay attention to when taking rivaroxaban? Unlike warfarin, rivaroxaban does not require monitoring of blood clotting indica...Read more
